Exhalation delivery systems (EDS) deliver medications to the internal nose. Developed in 2006, EDS devices use the patient's exhaled breath to propel medication, such as steroids, into the nasal cavities. The method can deliver medication deeper into the nasal passages than intranasal sprays, and at a lower pressure than nasal irrigation methods.
- Kuan, Edward C.; Kovacs, Alexander J.; Workman, Alan D.; Bosso, John V.; Adappa, Nithin D. (2019). "Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?". International Forum of Allergy & Rhinology. 9 (S1): S16–S21. doi:10.1002/alr.22340. ISSN 2042-6984.
|This medical article is a stub. You can help Wikipedia by expanding it.|